Khushal Choudhary
Internal Medicine · Providence, RINPI 1245885003
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,389 of the $10,055 with a category attached, or 63.5%. It is spread thinly across 33 manufacturers, the largest accounting for just 22.2%. 2025 is the largest year on record at $4,183, more than ten times the $163 reported in 2019. Among internal medicine clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 151 payments — averaging $66.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abbott$1K
- Abiomed$1K
- Johnson & Johnson$776
- AOP Health US, LLC$772
- Medtronic$679
- plus $3K from 27 others
What the payments were for
- Grants$1,75417%
- Travel & lodging$1,26213%
- Food & beverage$6,38964%
- Education$6506%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 11 | $2,229 |
| Abbott | 23 | $1,449 |
| Abiomed | 14 | $1,410 |
| Johnson & Johnson | 12 | $776 |
| AOP Health US, LLC | 2 | $772 |
| Medtronic | 8 | $679 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $349 |
| Cardiva Medical, Inc. | 14 | $346 |
| Shockwave Medical, Inc | 7 | $233 |
| Pfizer | 2 | $145 |
| Scpharmaceuticals Inc. | 2 | $142 |
| Nuwellis, Inc. | 1 | $125 |
| Chiesi USA, Inc. | 5 | $122 |
| Kestra Medical Technology Services, Inc. | 3 | $120 |
| Teleflex LLC | 4 | $119 |
| Gilead | 2 | $114 |
| Stryker | 3 | $106 |
| AstraZeneca(2 entities) | 5 | $106 |
| Philips North America LLC | 1 | $93 |
| Penumbra, Inc. | 3 | $85 |
| Merck | 4 | $81 |
| Bard Peripheral Vascular, Inc. | 3 | $71 |
| Heartflow, Inc. | 3 | $69 |
| Novartis | 3 | $67 |
| Biotronik Inc. | 3 | $50 |
| Getinge USA Sales, LLC | 1 | $39 |
| Sanofi-aventis U.S. LLC | 1 | $32 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| W. L. Gore & Associates, Inc. | 1 | $25 |
| Cook Medical LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Amgen | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rapiblyk$1,544
- Impella$1,001
- XARELTO$650
- CARDIOMEMS$268
- ENSITE$238
- ONYX FRONTIER$221
- LifeVest$209
- NAVITOR$159
- AVVIGO Guidance System$154
- AVEIR$130
- AQUADEX SMARTFLOW CONSOLE$125
- ELIQUIS$120
- FUROSCIX$112
- GALLANT$104
How this compares
$10,055 in reported general payments places this provider in the 95th percentile of 808 internal medicine providers in Rhode Island.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,862 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Providence
- Katarzyna Gilek-SeibertProvidence$131K
- Randall InghamProvidence$100K
- Richard RuggieriProvidence$30K
- Gerry OvideProvidence$29K
- Brian McCauleyProvidence$20K
- Meghan NahassProvidence$19K
- William LangProvidence$15K
- Abdelmoniem MoustafaProvidence$13K
- Kenneth ChenProvidence$9K
- Prahlad GadhaviProvidence$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.